24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet)

Autor: Daniela Bertens, Tobias Hartmann, Christian Mychajliw, Niels Andreasen, Merja Hallikainen, Thomas Leyhe, Epameinondas Lyros, Johannes Schröder, Lutz Frölich, Noel Ellison, Ineke van Rossum, Yawu Liu, Hans Klünemann, Jennifer Kennel, Anneke M.J. van Hees, Gerwin Roks, Mara ten Kate, Klaus Fassbender, Lars-Olof Wahlund, Matthias Riemenschneider, Frederik Barkhof, Stephan Schiekofer, Alina Solomon, Marcus O. W. Grimm, Hilkka Soininen, Aline Klees-Rollmann, Seppo Helisalmi, Lucrezia Hausner, Miia Kivipelto, Stina Lindblom, Kaj Blennow, Johanna Ml Henselmans, Niklas Koehler, Dieter Lütjohann, Christoph Laske, Göran Hagman, Philip Scheltens, Tarja Lappalainen, Suzanne Hendrix, Yvonne Freund-Levi, Maxine Luley, Daniela Ramelli, Pieter Jelle Visser, Robert Schomburg, Teemu Paajanen, Nienke M.E. Scheltens, Ilona Hallikainen

Publikováno v: The Lancet Neurology, 16(12), 965-975. Lancet Publishing Group
The Lancet. Neurology
Lancet Neurology, 16(12), 965-975. Elsevier Science
Soininen, H, Solomon, A, Visser, P J, Hendrix, S B, Blennow, K, Kivipelto, M, Hartmann, T & LipiDiDiet clinical study group 2017, ' 24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet) : a randomised, double-blind, controlled trial ', The Lancet Neurology, vol. 16, no. 12, pp. 965-975 . https://doi.org/10.1016/S1474-4422(17)30332-0

Background Nutrition is an important modifiable risk factor in Alzheimer's disease. Previous trials of the multinutrient Fortasyn Connect showed benefits in mild Alzheimer's disease dementia. LipiDiDiet investigated the effects of Fortasyn Connect on

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6f7f291b99a0117afc9dbe3f8653046
https://doi.org/10.1016/s1474-4422(17)30332-0